| 1 |
33816296 | LncRNA POU3F3 Contributes to Dacarbazine Resistance of Human Melanoma Through the MiR-650/MGMT Axis. | 2021 |
2 |
| 2 |
27997874 | Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients. | 2017 Jan |
1 |
| 3 |
26916096 | Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer. | 2016 Jun |
2 |
| 4 |
25400033 | MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma. | 2015 Jun 15 |
6 |
| 5 |
25584486 | O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents. | 2015 Feb 3 |
1 |
| 6 |
26113646 | Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer. | 2015 Sep |
4 |
| 7 |
24284332 | Impact of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine resistance of Hodgkin's lymphoma cells. | 2014 Jan |
4 |
| 8 |
25516857 | Role of MGMT as biomarker in colorectal cancer. | 2014 Dec 16 |
1 |
| 9 |
23422094 | Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer. | 2013 Apr 15 |
4 |
| 10 |
21811257 | Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours. | 2011 Sep 6 |
2 |
| 11 |
20541396 | MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC. | 2010 Jul |
6 |
| 12 |
19741564 | Effect of DNA repair host factors on temozolomide or dacarbazine melanoma treatment in Caucasians. | 2009 Oct |
5 |
| 13 |
17881774 | Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis. | 2007 Dec |
3 |
| 14 |
15870882 | Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest. | 2005 Jun |
5 |
| 15 |
16278661 | O6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts. | 2005 Nov 14 |
2 |
| 16 |
15010317 | Killing and mutagenic actions of dacarbazine, a chemotherapeutic alkylating agent, on human and mouse cells: effects of Mgmt and Mlh1 mutations. | 2004 Apr 1 |
2 |
| 17 |
14562026 | O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma. | 2003 Oct 20 |
5 |
| 18 |
12168066 | Immunohistochemical analysis of DNA mismatch repair protein and O6-methylguanine-DNA methyltransferase in melanoma metastases in relation to clinical response to DTIC-based chemotherapy. | 2002 Sep-Oct |
1 |
| 19 |
12170182 | Analysis of O(6)-methylguanine-DNA methyltransferase in melanoma tumours in patients treated with dacarbazine-based chemotherapy. | 2002 Aug |
6 |
| 20 |
10751609 | Toxicity, mutation frequency and mutation spectrum induced by dacarbazine in CHO cells expressing different levels of O(6)-methylguanine-DNA methyltransferase. | 2000 Feb 14 |
1 |
| 21 |
9071912 | Immunohistochemical examination of the expression of O6-methylguanine-DNA methyltransferase in human melanoma metastases. | 1997 Jan |
1 |
| 22 |
8645346 | Retrovirus-mediated transfer of the human O6-methylguanine-DNA methyltransferase gene into a murine hematopoietic stem cell line and resistance to the toxic effects of certain alkylating agents. | 1996 May 3 |
5 |
| 23 |
9038616 | Analysis of O6-methylguanine-DNA methyltransferase mRNA in fine needle biopsies from human melanoma metastases by reverse transcription and polymerase chain reaction. | 1996 Dec |
2 |